Patent Application
20140348986
Avocados are processed in a controlled manner to optimize and maintain the levels of mannoheptulose and perseitol in the avocado flesh.
Research spanning more than sixty years has shown that caloric restriction comprises a nutritional intervention that consistently extends longevity in humans and lower animals. In particular, pet food compositions have been reported that contain certain materials such as mannoheptulose that block or inhibit certain aspects of carbohydrate metabolism and may therefore mimic the effects of caloric restriction.
a. Mannoheptulose and its polyol form, perseitol, may be produced synthetically or may be extracted from natural plant sources, especially avocados. Manufacturers of human food compositions, as well as pet foods for dogs, cats, horses, ferrets and the like, are well-aware of the preference of their customers for naturally-derived ingredients in such compositions. Accordingly, the naturally-derived mannoheptulose and perseitol materials are preferred for food use and securing a source of such naturally-derived materials in an economically viable manner and on a large scale is key to the commercialization of food products containing these desirable materials.
b. From an economic standpoint, it would be quite advantageous to be able to use the avocado fruit, especially the peeled, depitted flesh of the fruit, as a natural source of mannoheptulose and perseitol. However, many varieties of avocado have been bred, not for their mannoheptulose/perseitol levels, but rather to provide a high oil content. Moreover, avocados can lose a considerable amount of their mannoheptulose during fruit ripening or even during post-harvest storage. Unfortunately, using unripened avocado fruit as a source of mannoheptulose and/or perseitol is quite problematic, due to the comparative toughness of the fruit's unripened flesh. Removing the pit from the unripened fruit also presents a considerable problem for the formulator, since it is held tenaciously by the tough avocado flesh. The peel is also difficult to remove.
c. Of course, it would be optimal to employ avocados that are not only in abundant supply, but also have the highest possible concentration of mannoheptulose and perseitol. The most common and abundant species of avocado that is grown in most orchards in the Northern Hemisphere is the “Hass”. Unfortunately, it has been determined that, while noted for its flavor and oil content, the Hass avocado is relatively low in mannoheptulose content, as compared with the West Indian and West Indian/Guatemalan hybrid varieties. Accordingly, those latter varieties are preferred for use herein.
As will be seen from the following disclosure, the process herein provides avocados that have been optimized with respect to both mannoheptulose/perseitol levels and with respect to removal of the pit and the peel from the fruit to provide the desired avocado flesh.
The present invention employs avocados harvested at a particular stage in their development to ensure optimal levels of mannoheptulose, perseitol and the like. The harvested fruit is then handled and processed in the manner developed herein to minimize losses of mannoheptulose, perseitol, and the like, due to natural processes.
The invention provides a process for treating avocados, comprising:
A.) harvesting the unripe fruit having a hardness greater than about 5 LBF (2.27 KF);
B.) contacting the fruit from step (A) with ethylene gas until the fruit exhibits a penetrometer reading greater than about 2 LBF (0.9 KF) and less than about 5 LBF (2.27 KF), especially about 4 LBF (1.81 KF), according to the Penetrometer Test Procedure; and
C.) terminating step (B) by a procedure selected from removing the avocados from contact with the ethylene gas, or cooling the avocados to a temperature optimally at or below about 45° F. (7° C.), or both, to provide an avocado product.
In another aspect, the process for treating avocados comprises:
a) harvesting the unripe fruit;
b) minimizing losses of mannoheptulose, perseitol, and the like, by cooling the whole fruit from step (a) to a temperature optimally at or below about 45° F., or by using the fruit in step (c) of the process within one week, optimally within about 48 hours of harvest, or both,
c) contacting the fruit from step (b) with ethylene gas until the fruit exhibits a penetrometer reading greater than about 2 LBF and less than about 5 LBF, according to the Penetrometer Test Procedure; and
d) terminating step (c) by a procedure selected from removing the avocados from contact with the ethylene gas, or cooling the avocados to a temperature optimally at or below about 45° F., or both, to provide an avocado product.
In the foregoing, “LBF” refers to pounds force and “KF” refers to kilograms force, per the Penetrometer Test Method, hereinafter.
In the aforementioned processes, the temperatures optimally are not below about 42° F. (5.5° C.) because this can cause cold damage to the fruit.
In one embodiment of the invention, the avocados used herein are selected from West Indian species and hybrids thereof with Guatemalan species, and mixtures thereof, and are especially of the criollo-type.
The process may further comprise a step selected from peeling the avocado product, de-pitting the avocado product, or both, especially comprising the steps of both peeling and de-pitting the avocado product to provide avocado flesh, optionally comminuting said flesh to provide a pulp and optionally freezing said pulp. Optionally, a further step may comprise adding a preservative such as a member selected from the group consisting of ascorbate preservatives, citrate preservatives and mixtures thereof to provide a frozen pulp composition. Ideally, the frozen pulp composition has a pH of about 4.5, or less, when thawed and the pH is measured on the macerated pulp without adding water. The acidic pH enhances stability.
In order to optimize levels of mannoheptulose and/or perseitol, the unripe avocado fruit is harvested and cooled at or below about 45° F. within 48 hours of harvesting. Optimally, the avocado fruit is harvested “early” in the season, as described hereinafter.
The process may further comprise the step of extracting a member selected from the group consisting of mannoheptulose, perseitol and mixtures thereof from the avocado product to provide the desired C7 materials, especially mannoheptulose and/or perseitol.
The invention also encompasses use of the avocado flesh obtained by the present process to prepare compositions for oral ingestion by humans and lower animals, especially pets such as cats and dogs. Such compositions typically comprise the flesh in an effective amount, i.e., a quantity that is sufficient to result in the desired physiological response in the user.
A typical composition for oral ingestion, comprises: (a) avocado flesh having a penetrometer reading greater than about 2 LBF and less than about 5 LBF, according to the Penetrometer Test Procedure in an amount sufficient to provide at least about 0.0001% of a member selected from the group consisting of mannoheptulose, perseitol and mixtures thereof, by weight of said composition; and (b) an additive selected from the group consisting of protein, fat, carbohydrate, vitamins, minerals, and mixtures of said additives.
In a non-limiting embodiment, such compositions optimally comprise sufficient avocado flesh to provide from about 0.0001% to about 0.5%, of mannoheptulose, by weight of said composition. One embodiment is a pet food composition in the form of a kibble, or a treat, or a nutritional supplement, especially an extruded pet food composition comprising non-avocado protein. Such compositions may typically comprise at least about 5.0%, by weight, of animal protein. Another such pet food composition comprises at least about 5.0%, by weight, non-avocado derived carbohydrate. Yet another pet food composition comprises at least about 1.0%, by weight, of non-avocado derived fat comprising omega-3 unsaturated fatty acid moieties.
A pet food composition comprising from about 0.01% to about 0.5%, by weight of mannoheptulose is especially useful with companion animals such as dogs and cats to provide the various physiological benefits described herein.
This application claims the benefit of U.S. Provisional Application Ser. No. 61/826,516, the entirety of which is incorporated by reference herein.
As used herein, “mannoheptulose” means the well-known 7-carbon atom monosaccharide C7H14O7, also commonly referred to as “D-mannoheptulose.” “Perseitol” has the empirical formula C7H16O7 and is the polyol, i.e., reduced, form of mannoheptulose. Such compounds may be referred to as “C7” materials.
Various other desirable C6 and C7 antimetabolite materials available from the avocado include, but are not limited to: 2-deoxy-D-glucose; 5-thio-D-glucose; 3-O-methylglucose; 1,5-anhydro-D-glucitoc; 2,5-anhydro-D-glucitol; 2,5-anydro-D-mannitol; and mixtures thereof with each other and with perseitol and mannoheptulose. As disclosed hereinafter, it has now been discovered that the criollo avocado is an unexpectedly rich source of both mannoheptulose and perseitol. Accordingly, processes that embody the use of criollo avocado to provide a mixture of mannoheptulose and perseitol comprise especially useful, but non-limiting, embodiments of the present invention.
As used herein, “persin” is the known, oil-soluble, non-sugar materials that may be present in avocado. Reportedly, excessive amounts of persin in the diet may not be well-tolerated by some species of animal.
As sued herein, avocado “flesh” means the avocado fruit material without the pit and without the peel.
All percentages, parts and ratios as used herein are by weight of the total composition, unless otherwise specified. All such weights as they pertain to listed ingredients are based on the active level and, therefore do not include solvents or by-products that may be included in commercially available materials, unless otherwise specified. All numerical units are within the normal degree of accuracy afforded by the art, unless otherwise specified.
The present invention employs West Indian or hybrids of West Indian/Guatemalan avocados. By “West Indian” herein is meant the well-characterized botanical species Persea americana var. americana. By “Guatemalan” is meant Persea americana var. guatemalensis. By “West Indian Hybrid” herein is meant hybrids obtained by combining said West Indian and Guatemalan species.
Non-limiting examples of West Indian and West Indian/Guatemalan hybrid avocados for use herein include the following:
West Indian—Butler; Fuchs; General Bureau; Maoz; Pollock; Ruchle; Russell; Simmonds; Trapp; Waldin; Alzamora; Avila; Faria; Garcia; Hernandez; St. Just; Amador; Galo; Gimenez; Lewis; Torres; Trujillo; Yamagata.
West Indian/Guatemalan Hybrids—Bonita; Booth 1; Booth 7; Booth 8; Chequette; Collinson; Fuchs-20; Grande; Hall; Herman; Hickson; Kahaluu; Simpson; Winslowson; Gripina 2; Gripina 5; Gripina 12; Semil 23; Semil 31; Semil 34; Semil 42; Semil 43, Semil 44.
Such avocados are typically domesticated using standard horticultural techniques such as pruning, fertilizing, irrigating, treating with pesticides and the like, and contain the desired mannoheptulose and/or perseitol compounds at levels typically that are commercially useful when the fruit is processed in the present manner to provide the avocado flesh without pit or peel.
In conjunction with the optimized processing conditions provided by the present invention, it has now been discovered that the so-called “criollo” avocado is an unexpectedly rich source of mannoheptulose and perseitol and is highly preferred for use in the present process and compositions. The criollo avocado used herein comprises the undomesticated tropical West Indian and West Indian/Guatemalan hybrid species found growing generally in a band between 25° north and 25° south latitudes. In particular, the criollo now discovered to have the highest mannoheptulose and perseitol levels grows in the Dominican Republic, especially in mountainous regions. Criollo avocados are available in sufficient quantities to be usable as a commercial source of these C7 materials in the present manner. Suppliers include Fresh Directions Dominicana in the Dominican Republic and Brooks Tropicals in Florida, USA.
The criollo avocado has been largely ignored, other than for local usage mainly in its region of origin and its use as a source of mannoheptulose and/or perseitol in the manner of this invention seems to have gone unreported. Since the criollo is undomesticated, it grows in an uncultivated state without fertilization, artificial irrigation and pesticides. Unlike the more familiar avocado species, the criollo trees are typically not pruned and their height makes them easy to distinguish from their shorter, cultivated counterparts. Their fruit tends to be relatively large, green and smooth-skinned.
Except for the present invention, it is unlikely that the criollo avocado would ever have been considered of major commercial interest outside its locale of origin, because edible avocados are generally bred for their high fat content, i.e., as avocado oil, not for their mannoheptulose and perseitol content. For example, while the mannoheptulose content of the flesh of the Hass avocado averages only about 1.4% (wt.) in the unripe fruit and decreases considerably in the ripe fruit, the flesh of the criollo averages about 2.1% (wt.) mannoheptulose in the unripe fruit, and does not decrease in flesh of criollo fruit processed in the manner of this invention. The high level of mannoheptulose in the criollo and its unexpected retention, or even increase, after processing in the present manner make the criollo uniquely suited for commercial use as a source of these C7 materials. For further perspective, the Hass fruit, treated under the unique process developed herein, has about 0.57% mannoheptulose versus the much higher mannoheptulose levels from criollo. In sharp contrast, typical mannoheptulose levels in conventional, commercial Hass fruit are not measurable, or are less than 0.1%.
Moreover, the content of the other important avocado-derived sugars has now also been found to be considerably greater in the flesh of the criollo avocado than in cultivated avocados, such as the Hass. For example, the Hass averages 473 ppm glucose and 5,981 ppm perseitol in the unripe fruit and 1,421 ppm glucose and 621 perseitol in the ripe fruit. In sharp contrast, the West Indian type criollo avocado averages 931 ppm glucose in the unripe fruit and 1,985 ppm in the ripe fruit and 14,207 ppm perseitol in the unripe fruit and 11,963 ppm in the ripe fruit.
It should be noted that the levels of C7 compounds can vary with avocado species, depending on the time of harvest. In general, the early-harvest fruit has the highest levels of mannoheptulose and is therefore optimal for use herein. It is well-know, to growers that the various species have differing harvest times. Harvest time is established by such factors as fruit size or weight. June is considered “early” harvest for criollo, whereas late September is early harvest for Semil 34. In any event, the key is to harvest the fruit when it reaches its peak level of mannoheptulose or mannoheptulose plus perseitol. If desired, the chromatographic analysis disclosed hereinafter could be used to establish peak levels quantitatively and provide a definition of “early” harvest times. However, reliance on the skill of the grower to judge when to harvest “early” is usually sufficient. In contract to early harvest, “late” harvest is when the oil content of the fruit is typically greatest. Different from the present process, “late” harvest is more generally the norm in the industry, since the oily late harvest avocados have the organoleptic quantities typically desired in human food.
Avocado Treatment with Ethylene Gas
As noted above, avocados harvested early in the season tend to have higher mannoheptulose levels than those harvested late in the season. Accordingly, the processing conditions are described herein are for avocados harvested early in the season. The fruit is monitored every 4 hours throughout the ethylene gas treatment stage of the process herein to ensure that it does not reach penetrometer readings below the 2 LBF limit, since that results in unacceptable losses of mannoheptulose. One objective of the process is to treat the avocados with the ethylene gas just to the point where the pit can be removed with a tablespoon, i.e., are “spoonable” and the peel is also readily removed. Accordingly, the process is monitored to ensure that the fruit does reach penetrometer readings of <5 LBF. The proper balance between optimal mannoheptulose/perseitol levels and the spoonable state correspond quite well with the target penetrometer readings of >2 and <5 LBF, as described in more detail, below.
While the process herein is useful with all domesticated and undomesticated West Indian and West Indian/Guatemalan hybrid avocados, the operating conditions disclosed hereinafter focus on the criollo-type, since those are of highest commercial interest. A novel and quite unexpected advantage of the criollo over avocados such as the Hass is the criollo's shortened treatment time. In general terms, exposing criollo avocados to an atmosphere of ethylene gas for about one day is sufficient treatment, whereas the Hass requires about three days. This, of course, represents a considerable processing advantage for the criollo.
As a general proposition, all avocado fruit that is harvested later in the season may reach the spoonable state even faster than 24 hours; hence, regularly monitoring whether the pit can be removed by hand and especially monitoring the penetrometer readings are important for achieving the desired avocado flesh from the process. While each batch of fruit may be somewhat different, the formulator can always use these tests to indicate readiness of the fruit to be used, as is, or to be converted into pulp.
In a typical, but non-limiting, process the criollo avocado is exposed to ethylene gas in a “ripening room” for about 24 hours. Ripening room conditions: temp. 18-22° C., ethylene gas at 100 ppm; humidity 95-99%; room is vented and air is circulated.
As noted above, the appropriate point to discontinue ethylene treatment can be measured using the penetrometer and can also be judged by the so-called “spoon test,” i.e., the treatment is judged to be complete when the pit is easily separated from the flesh by hand manipulation of a common eating spoon. In some instances, the pit can become so loose in the treated fruit that it actually moves when the whole fruit is shaken. This is yet another unexpected advantage of the criollo for formulators who wish to remove the criollo's pit (and, optionally, also the skin) in order to use the “flesh only” material.
Various, optional aspects of the processing are disclosed hereinafter, not by way of limitation, but solely for the convenience of the formulator. A chromatographic method for quantitatively analyzing the content of mannoheptulose and other sugars is also disclosed hereinafter.
In one aspect the harvested avocados used in the process are all of the same general size (±15-20%). This helps ensure that all avocados in any batch being contacted by the ethylene gas reach the target penetrometer reading at the same time. In another aspect, the avocados may optionally, but preferably, be sanitized before processing, e.g., by exposure for one minute to 200 ppm chlorine. After processing, the avocados may be cut in half, for example with a circular blade on automated equipment, and the pits removed (e.g., manually) using a spoon. Peeling provides the avocado flesh. Peeling and removing the pit may help reduce persin content of the product to nearly imperceptible, or even zero, levels that are entirely acceptable for ingestion. The avocado flesh can then optionally be mixed with preservatives such as food grade sulphites or ascorbic acid, citric acid, or mixtures thereof and optionally bagged (e.g., vacuum packaged) and preferably frozen for later use. Ascorbic acid (or salts thereof) is typically used at 0.1-0.5 wt %; citric acid (or salts thereof) is typically used at 0.1-0.5 wt. %. An especially useful preservative for frozen criollo flesh comprises a mixture of 0.3% ascorbic acid and 0.16% citric acid, by wt. of the flesh. Various processing safeguards, such as metal detectors, can be used to ensure product safety, hygiene and the like.
The 90 day mannoheptulose stability of the avocado pulp stored frozen (−20° C.) is: Semil 10.4% loss in 90 days; criollo 11.0% loss in 90 days.
Use of the frozen avocado flesh to prepare food compositions for human or animal use may comprise breaking/crushing frozen blocks of the flesh, which is used as is, or by adding water to provide a flowable paste; and optionally standardizing the paste to a target mannoheptulose and/or perseitol content by further dilutions with water.
The penetrometer measures the force required to push a plunger tip having a specified size into the avocado flesh. These force readings assist in determining the appropriate avocado harvesting time and to monitor fruit softening during treatment with ethylene gas.
When the fruit to be tested is removed from the ethylene treatment its temperature is in the 18-22° C. range and the penetrometer test is run while the fruit is at that temperature range. Penetrometer readings are taken at two locations on the fruit using a Wagner Penetrometer Model No. FT40 with Gage FDK40 with a 13 mm tip. This has a capacity of 40 LBF (18.18 KF) and accuracy of ±1 graduation. A 13 mm tip is used. The meter is used with the Wagner FTK test stand.
1. A thin disc of skin is removed with the Wagner FT/PRL fruit peeler on the fruit midway between the stem ad the bottom of the fruit. Then the fruit is rotated approximately 45 degrees and a second disc of skin is removed with the peeler. These are the test sites for the penetrometer.
2. Place the avocado in the Wagner FTK Test Stand for controlled testing.
3. Force the tip vertically into the flesh at a constant, slow speed (take 3 seconds) and the tip should penetrate to the break in the scribed line on the tip or the break in the tip.
4. Record the reading in LBF (pounds force) to the nearest graduation.
5. The two readings are averaged.
The fruit must all be approximately the same size and weight for penetrometer testing. In a typical mode, three avocados at a minimum are tested from a batch undergoing contact with the ethylene at each stage of monitoring. The monitoring is conducted every four hours. Monitoring is discontinued when the target >2 LBF to <5 LBF range is reached. Penetrometer testing of fruit to be harvested can be done in the field. In general, the freshly harvested fruit will be very firm and have a penetrometer reading greater than 5 and can exceed 20.
Avocado flesh processed in the present manner provides components selected from 2-deoxy-D-glucose; 5-thio-D-glucose; 3-O-methylglucose; 1,5-anhydro-D-glucitol; 2,5-anhydro-D-glucitol; 2,5-anhydro-D-mannitol; mannoheptulose; perseitol; and mixtures and combinations thereof. Usage will depend upon the size and condition of the human or lower animal to which the compounds or mixtures are to be administered. Usage amounts in the range of about 0.0001 or about 0.001 grams/kg to about 1 g/kg can be beneficial in some embodiments, especially for mannoheptulose. As used herein, when amounts in mg/kg is used, the “mg” refers to the level of the component, such as mannoheptulose, and “kg” refers to kilograms of body weight of the mammal, including humans as well as a pet, such as a dog or cat. Usage at the lower range may also be appropriate when using 2-deoxy-D-glucose in large animals. Higher amounts, particularly of compounds such as 5-thio-D-glucose or mannitol, may also be readily tolerated. In one embodiment, the compound provided to a mammal on a daily basis may be from about 0.1, 0.5, 1, 2, or 5 mg/kg to about 15, 20, 50, 100, 150, or 200 mg/kg, and all combinations of these ranges. In one embodiment, the amount, on a daily basis, may be from about 1 mg/kg to about 15 mg/kg, from about 2 mg/kg to about 10 mg/kg, or from about 2 mg/kg to about 5 mg/kg. In one embodiment, the amount fed to the mammal, on a daily basis, may be from about 1 mg/kg to about 5 mg/kg, from about 1.5 mg/kg to about 5 mg/kg, from about 2 mg/kg to about 5 mg/kg, or about 2 mg/kg. In certain embodiments, these amounts may translate to compositions comprising mannoheptulose and/or perseitol less than about 5%, or less than about 2%, or from about 0.0001% to about 0.5%, or from about 0.1% to about 10%, or from about 0.1% to about 5%, of the component, all by weight of the composition. All ranges there between are envisioned. The level of component may be determined by one of ordinary skill in the art based on a variety of factors, for example, the form of the composition (e.g., whether a dry composition, semi-moist composition, wet composition, or supplement, or any other form or mixture thereof). The ordinarily skilled artisan will be able to utilize the preferred amount to be fed and determine the optimal level of component within a given feed composition.
Similarly, the overall amount of the component on a daily basis provided to the mammal can be from about 0.1 mg per day to about 1000 mg per day. Such daily amounts can be dependent on the size of the mammal consuming the composition. For example, in one embodiment, larger mammals may consume more than smaller mammals. Of course, that is consistent with the amounts disclosed herein with respect to the amount per mass of the mammal. Thus, in one embodiment, as the mammal increases in size, more of the composition can be fed.
Accordingly, in one embodiment, such a daily amount can correspond to the amount on a daily basis per mass of the mammal, as described herein. Specifically, daily amounts can range, in some embodiments, from about 0.1 mg per day to about 1000 mg per day, or even more, depending on the size of the mammal and the daily amounts as described above. In other embodiments, the daily amount can be from about 1 mg per day to about 500 mg per day, or from about 1 mg per day to about 200 mg per day, or from about 1 mg per day to about 100 mg per day, or from about 5 mg day per day to about 100 mg per day, or from about 5 mg per day to about 80 mg per day, or from about 10 mg per day to about 50 mg per day, or about 40 mg per day. All ranges there between are also envisioned.
As noted, embodiments of the invention are directed to a composition that is intended for ingestion by a mammal. Compositions include foods intended to supply necessary dietary requirements, as well as treats (e.g., biscuits) or other food supplements. Optionally, the composition herein may be a dry composition (for example, kibble), semi-moist composition, wet composition, or any mixture thereof. Alternatively or additionally, the composition is a supplement, such as a gravy, drinking water, yogurt, powder, suspension, chew, treat (e.g., biscuits) or any other delivery form.
The compositions herein can be complete and nutritionally balanced. A complete and nutritionally balanced composition may be compounded to be fed as the sole ration and is capable of maintaining life without any additional substance being consumed, except for water. Alternatively, the composition can be a nutritional supplement that is administered in addition to routine feeding.
The compositions used herein may optionally comprise one or more further components. Other components are beneficial for inclusion in the compositions used herein, but are optional for purposes of the invention. In one embodiment, the compositions may comprise, on a dry matter basis, from about 10% to about 90% crude protein, alternatively from about 20% to about 50% crude protein, alternatively from about 20% to about 40% crude protein, by weight of the composition, or alternatively from about 20% to about 35% crude protein, by weight of the composition. The crude protein material may comprise vegetable-based proteins such as soybean, cereals (corn, wheat, etc), cottonseed, and peanut, or, more preferably, animal-based proteins such as casein, albumin, and meat protein. Non-limiting examples of meat protein useful herein include a protein source selected from the group consisting of beef, pork, lamb, poultry, fish, and mixtures thereof.
Furthermore, embodiments of the compositions may comprise, on a dry matter basis, from about 5% to about 40% fat, alternatively from about 10% to about 35% fat, by weight of the composition.
Embodiments of the compositions of the invention may comprise a source of carbohydrate. In one embodiment, the compositions may comprise from about 35%, by weight of the composition, up to about 50%, by weight of the composition, carbohydrate source. In other embodiments, the composition can comprise from about 35% to about 45%, by weight of the composition, or from about 40% to 50%, by weight of the composition, carbohydrate source. Grains or cereals such as rice, corn, milo, sorghum, barley, wheat, and the like are illustrative sources of carbohydrate. Corn levels can range to 80%, or more.
The compositions may also contain other materials such as, but not limited to, dried whey and other dairy by-products, beet pulp, cellulose, fiber, fish oil, flax, vitamins, minerals, flavors, antioxidants, and taurine.
The compositions may also contain other optional ingredients. Optional ingredients can include Probiotic components (Bifidobacteria and/or Lactobacillus) and Prebiotic (fructooligosaccharides) components. Examples and amounts of Probiotic components and Prebiotic components that can be included are disclosed in United States Publication No. 2005/0158294, for example. Other optional ingredients that can be included are omega 6 and omega 3 fatty acids, carnitine, hexametaphosphate, glucosamine, chondroitin sulfate, carotenoids including beta carotene, vitamin E, and lutein and mixtures thereof.
Table 1 illustrates two kibble compositions having the following components at the approximate indicated amounts are prepared using methods which are standard in the art, including extrusion, and are fed to dogs and/or cats as a daily feed:
The following examples further describe and demonstrate embodiments within the scope of the invention. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention. All of the following examples are compositions that are utilized by a human or lower animal.
The dry compositions of Examples A-F can be made by first milling and mixing the cereal grains with protein meal, egg products, vitamins and minerals and fiber sources and avocado flesh or mannoheptulose or glucose anti-metabolite. Then, add the mixed, dried ingredients to the meat products and fat sources. Extrude the ingredients into kibbles. Dry the kibbles. Package the finished product.
In addition to proteinaceous, farinaceous, vitamin and mineral materials, the compositions of the invention generally may include other optional additives such as flavorings, preservatives, emulsifiers and humectants. The nutritional balance, including the relative proportions of vitamins, minerals, protein, fat and carbohydrate, is determined according to dietary standards known in the veterinary and nutritional art. The following ranges are simply for illustration purposes and are not intended to be limiting.
Nonlimiting examples of dry compositions may optionally contain on a dry matter basis, from about 1% to about 50% crude protein, from about 0.5% to about 25% crude fat, from about 1% to about 10% supplemental fiber, all by weight of the composition. The dry composition may have a total moisture content from about 1% to about 30% moisture. Alternatively, a dry composition may contain on a dry matter basis, from about 5% to about 35% crude protein, from about 5% to about 25% crude fat, from about 2% to about 8% supplemental fiber, all by weight of the composition. The dry composition may have a total moisture content from about 2% to about 20% moisture. Alternatively, the dry composition contains on a dry matter basis, a minimum protein level of about from about 9.5% to about 35%, a minimum fat level of from about 8% to about 20%, a minimum supplemental fiber level of from about 3% to about 7%, all by weight of the composition. The dry animal composition may also have a minimum metabolizable energy level of about 3.5 Kcal/g. The dry composition may have a total moisture content from about 3% to about 10%.
Nonlimiting examples of a semi-moist composition may optionally contain on a dry matter basis, from about 0.5% to about 50% crude protein, from about 0.5% to about 25% crude fat, from about 0.5% to about 15% supplemental fiber, all by weight of the composition. The semi-moist composition may have a total moisture content from about 30% to about 50% moisture. Alternatively, the semi-moist compositions may contain on a dry matter basis, from about 5% to about 35% crude protein, from about 5% to about 25% crude fat, from about 1% to about 5% supplemental fiber, and all by weight of the composition. The semi-moist composition may have a total moisture content from about 35% to about 45% moisture. Alternatively, the semi-moist composition may have on a dry matter basis, a minimum protein level of about from about 9.5% to about 22%, a minimum fat level of from about 8% to about 13%, a minimum supplemental fiber level of from about 2% to about 3%, all by weight of the composition. The semi-moist composition may have a total moisture content from about 38% to about 42%. The semi-moist composition may also have a minimum metabolizable energy level of about 3.5 Kcal/g and from about 0.1% to about 20% ash, and from about 0.001% to about 5.0% taurine.
Nonlimiting examples of a moist composition may optionally contain on a dry matter basis, from about 0.5% to about 50% crude protein, from about 0.5% to about 25% crude fat, from about 0.01% to about 15% supplemental fiber, all by weight of the composition. The moist composition may have a total moisture content from about 50% to about 90% moisture. Alternatively, the moist compositions may contain on a dry matter basis, from about 5% to about 35% crude protein, from about 5% to about 25% crude fat, from about 0.05% to about 5% supplemental fiber, all by weight of the composition. The moist composition may have a total moisture content from about 60% to about 85% moisture. Alternatively, a moist animal composition may contain on a dry matter basis, a minimum protein level of about from about 9.5% to about 22%, a minimum fat level of from about 8% to about 13%, a minimum supplemental fiber level of from about 0.1% to about 3%, all by weight of the composition. The moist composition may have a total moisture content from about 65% to about 80%. The moist composition may also have a minimum metabolizable energy level of about 1.0 Kcal/g and from about 0.1% to about 20% ash, and from about 0.001% to about 5.0% taurine.
In one embodiment of the present invention, the composition, whether dry, moist, semi-moist or otherwise, comprises on a dry matter basis, from about 5% to about 50%, alternatively 20% to about 50% of animal-derived ingredients, by weight of the composition. Non-limiting examples of animal-derived ingredients include chicken, beef, pork, lamb, turkey (or other animal) protein or fat, egg, fishmeal, and the like.
Where the composition is in the form of a gravy, the composition may comprise at least 10% of a broth, or stock, non-limiting examples of which include vegetable beef, chicken or ham stock. Typical gravy compositions may comprise on a dry matter basis, from about 0.5% to about 5% crude protein, and from about 2% to about 5% crude fat.
Where the composition is in the form of a supplement or “treat,” such as biscuits, chews, and other treats, the supplement may comprise, on a dry matter basis, from about 20% to about 60% protein, from about 22% to about 40% protein, by weight of the supplement composition. As another non-limiting example, the compositions may comprise a supplement comprising a dry matter basis, from about 5% to about 35% fat, or from about 10% to about 30% fat, by weight of the supplement composition, along with optimal vitamins and minerals. Compositions, treats and supplement compositions intended for use by animals such as cats or dogs are commonly known in the art.
The compositions of the present invention can further comprise a wide range of other optional ingredients. It is to be understood that they can include vegetables, non-avocado fruit, egg-based materials, undenatured proteins, food grade polymeric adhesives, gels, polyols, starches, gums, seasonings, salts, colorants, time-release compounds, minerals, vitamins, antioxidants, aroma modifiers, textured wheat protein, textured soy protein, textured lupin protein, textured vegetable protein, breading, flour, comminuted pasta, and combinations thereof.
Other examples of optional ingredients can include at least one vegetable. Nonlimiting examples of vegetables include carrots, peas, potatoes, cabbage, celery, beans, corn, tomatoes, broccoli, cauliflower, leeks and combinations thereof.
Also useful herein, as an optional ingredient, is a filler. The filler can be a solid, a liquid or packed air. The filler can be reversible (for example thermo-reversible including gelatin) and/or irreversible (for example thermo-irreversible including egg white). Nonlimiting examples of the filler include gravy, gel, jelly, aspic, sauce, water, air (for example including nitrogen, carbon dioxide, and atmospheric air), broth, and combinations thereof.
Nonlimiting examples of colorants include, but are not limited to, synthetic or natural colorants, and any combination thereof. When present the colorants are from about 0.0001% to about 5%, from about 0.001% to about 1%, from about 0.005% to about 0.1%, on a dry matter basis, of said colorant.
Also useful herein, as an optional ingredient, is at least one non-avocado fruit. Nonlimiting examples include tomatoes, apples, pears, peaches, cherries, apricots, plums, grapes, oranges, grapefruit, lemons, limes, cranberries, raspberries, blueberries, watermelon, cantaloupe, muskmelon, honeydew melon, strawberries, banana, and combinations thereof.
The compositions may optionally contain other materials such as dried whey and other dairy by-products.
The compositions may optionally contain other active agents such as long chain fatty acids and zinc. Suitable long chain fatty acids include alpha-linoleic acid, gamma linolenic acid, linoleic acid, eicosapentanoic acid, and docosahexanoic acid. Fish oils are a suitable source of eicosapentanoic acids (EPA) and docosahexanoic acid (DHA). A useful DHA level is at least about 0.05%, alternatively at least about 0.1%, alternatively at least about 0.15% of the animal food composition, all on a dry matter basis. A useful EPA level is at least about 0.05%, alternatively at least about 0.1%, alternatively at least about 0.15% of the animal food composition, all on a dry matter basis.
This method is for the analysis of perseitol, mannoheptulose, glucose, sucrose, and fructose in avocado raw material and dry pet food. The method involves extraction of sugars with 18.2 mΩ water followed by separation of sugars on an IC column with electrochemical detection.
Stock standard solution is stable for 2 months when stored in the refrigerator. Approximate concentration of each sugar in the stock solution is 10 ug/mL. Allow the stock standard to reach room temperature before making dilutions.
Prepare linearity standards by dilution of the specified volume of stock into the clear autosampler vials indicated. Dilute to volume with 18.2 mΩ purified water.
Linearity standards in autosampler vials are stable for a week after they are prepared. They are to be stored in the instrument autosampler at 4° C. They are to be discarded at the end of the week.
Prepared samples are stable for 1 week in autosampler vials stored in the instrument at 4° C. Control sample is extracted using the same procedure as unknown samples.
Extraction step contains a 1:10 dilution for all samples. Different samples will require different dilution strategies. Below are a set of standard dilution strategies.
Eluent A (18.2 mΩ Water): Triple rinse eluent reservoir with 18.2 mΩ water and fill it up to 1.8 L mark with 18.2 mΩ water. Degas for 20 minutes with nitrogen while stirring on a stirring plate. Immediately after degassing, place the reservoir on top of the instrument and cap under nitrogen. Eluent A is stable for 2 weeks.
Eluent B (0.2M NaOH): Degas 2 L of 18.2 mΩ water in a 2 L eluent bottle for 20 minutes. Using a transfer pipette, transfer 21 ml of 50% NaOH from the center portion of the 50% NaOH container to a 2 L volumetric flask. (Do not shake the 50% NaOH container. Do not transfer NaOH from the bottom or the top portion of the container to avoid contamination from sodium bicarbonate precipitate. Do not pour NaOH from the container since carbonate flakes collect around the container rim.) Transfer the NaOH slowly into the 2 L volumetric flask and fill up to the mark with 18.2 mΩ water. Cap, invert to mix the solution.
Slowly pour the solution to an eluent reservoir and degas for 20 minutes with nitrogen. Immediately after degassing, place the reservoir on top of the instrument and cap. Eluent B is stable for 3 months.
Eluent C (1M NaOH): Degas 2 L of 18.2 mΩ water in a 2 L eluent bottle for 20 minutes. Using a transfer pipette, transfer 104.6 ml of 50% NaOH from the center portion of the 50% NaOH container to a 2 L volumetric flask. (Do not shake the 50% NaOH container. Do not transfer NaOH from the bottom or the top portion of the container to avoid contamination from sodium bicarbonate precipitate. Do not pour NaOH from the container since carbonate flakes collect around the container rim.) Transfer the NaOH slowly into the 2 L volumetric flask and fill up to the mark with 18.2 mΩ water. Cap, invert to mix the solution. Slowly pour the solution to an eluent reservoir and degas for 20 minutes with nitrogen. Immediately after degassing, place the reservoir on top of the instrument and cap. Eluent C is stable for 3 months.
Eluent D (2M NaOH): Degas 2 L of 18.2 mΩ water in a 2 L eluent bottle for 20 minutes. Using a transfer pipette, transfer 209.2 ml of 50% NaOH from the center portion of the 50% NaOH container to a 2 L volumetric flask. (Do not shake the 50% NaOH container. Do not transfer NaOH from the bottom or the top portion of the container to avoid contamination from sodium bicarbonate precipitate. Do not pour NaOH from the container since carbonate flakes collect around the container rim.) Transfer the NaOH slowly into the 2 L volumetric flask and fill up to the mark with 18.2 mΩ water. Cap, invert to mix the solution. Slowly pour the solution to an eluent reservoir and degas for 20 minutes with nitrogen. Immediately after degassing, place the reservoir on top of the instrument and cap. Eluent D is stable for 3 months.
Flow: 0.4 mlimin
Run Time: 52 minutes
Chromatographic Sequence:
Inject the 18.2 mΩ at least one time at the start of each run.
Inject linearity standards 1 through 5 once each before and after the samples.
Inject the control sample once each before and after the samples.
Report results in ppm to four significant figures for each sugar. For example, 100.1 ppm.
Chromatographic separation of the various materials of interest herein yields quite distinct elution times, which allows them to be readily identified and quantified. Representative elution times are shown in Table 1.
It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every numerical range given throughout this specification includes every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
All documents cited in the Detailed Description of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention.
While particular embodiments of the present invention have been illustrated and described, it would be clear to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
| Number | Date | Country | |
|---|---|---|---|
| 61826516 | May 2013 | US |
